Aimei Health Technology Co., Ltd
NASDAQ: AFJK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Junheng Xie
- Employees
- 2
- Headquarters
- New York City, United States
- IPO year
- 2024
- Market cap
- $175.1M
- Website
- https://www.aimeihealth.com
Loading AFJK…
Loading profile data…Frequently asked questions about AFJK
What does Aimei Health Technology Co., Ltd (AFJK) do?
Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acqui...
Where does AFJK trade?
Aimei Health Technology Co., Ltd (AFJK) trades on the NASDAQ Global Market.
What sector is AFJK in?
Aimei Health Technology Co., Ltd (AFJK) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of Aimei Health Technology Co., Ltd?
Junheng Xie is the chief executive officer of Aimei Health Technology Co., Ltd (AFJK).
Where is Aimei Health Technology Co., Ltd headquartered?
Aimei Health Technology Co., Ltd is headquartered in United States.
Does AFJK pay a dividend?
Aimei Health Technology Co., Ltd (AFJK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AFJK go public?
Aimei Health Technology Co., Ltd (AFJK) completed its initial public offering in 2024.